In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics
- PMID: 8852472
- DOI: 10.1007/BF01780660
In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics
Abstract
Minimal inhibitory concentrations (MIC) and minimal bactericidal concentrations (MBC) were evaluated of the antimicrobial chemotherapeutics amoxicillin, azithromycin, cefotaxime, ceftriaxone, doxycycline, penicillin G sodium, roxithromycin, and trimethoprim-sulfamethoxazole for 30 Borrelia strains from various sources (skin, cerebrospinal fluid, ticks). Of these strains 29 were Lyme disease agents of the species Borrelia afzelii (n = 12), Borrelia burgdorferi sensu stricto (n = 4), Borrelia garinii (n = 13), and one was the relapsing fever strain Borrelia turicatae (n = 1). Tests were performed in microtiter plates by broth dilution. MIC was determined after 72 hours of incubation by comparing growth control with the antibiotic dilutions by means of dark field microscopy. Strains tested were susceptible against amoxicillin, azithromycin, cefotaxime, ceftriaxone, doxycycline, and penicillin G sodium, partly susceptible to roxithromycin, and resistant to trimethoprim-sulfamethoxazole. No statistically significant differences in MIC and MBC were seen among the different antibiotics with the various Borrelia species.
Similar articles
-
In Vitro Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents.Antimicrob Agents Chemother. 2017 Aug 24;61(9):e00535-17. doi: 10.1128/AAC.00535-17. Print 2017 Sep. Antimicrob Agents Chemother. 2017. PMID: 28674060 Free PMC article.
-
Sensitivity of Borrelia burgdorferi strains isolated in the Czech Republic.Cent Eur J Public Health. 2001 Feb;9(1):38-40. Cent Eur J Public Health. 2001. PMID: 11243589
-
Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis.Infection. 1996 Jan-Feb;24(1):9-16. doi: 10.1007/BF01780643. Infection. 1996. PMID: 8852456
-
Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know.Wien Klin Wochenschr. 2006 Nov;118(21-22):659-68. doi: 10.1007/s00508-006-0693-z. Wien Klin Wochenschr. 2006. PMID: 17160604 Review.
-
Isolation techniques for spirochetes and their sensitivity to antibiotics in vitro and in vivo.Rev Infect Dis. 1989 Sep-Oct;11 Suppl 6:S1505-10. doi: 10.1093/clinids/11.supplement_6.s1505. Rev Infect Dis. 1989. PMID: 2682963 Review.
Cited by
-
In Vitro Susceptibility of Treponema pallidum subsp. pallidum to Doxycycline.Antimicrob Agents Chemother. 2020 Sep 21;64(10):e00979-20. doi: 10.1128/AAC.00979-20. Print 2020 Sep 21. Antimicrob Agents Chemother. 2020. PMID: 32718967 Free PMC article.
-
Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment.J Clin Microbiol. 1997 Jan;35(1):111-6. doi: 10.1128/jcm.35.1.111-116.1997. J Clin Microbiol. 1997. PMID: 8968890 Free PMC article.
-
Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability.J Clin Microbiol. 2013 Mar;51(3):857-62. doi: 10.1128/JCM.02785-12. Epub 2012 Dec 26. J Clin Microbiol. 2013. PMID: 23269733 Free PMC article.
-
In Vitro Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents.Antimicrob Agents Chemother. 2017 Aug 24;61(9):e00535-17. doi: 10.1128/AAC.00535-17. Print 2017 Sep. Antimicrob Agents Chemother. 2017. PMID: 28674060 Free PMC article.
-
Distribution of Borrelia burgdorferi sensu lato genomic groups in Europe, a review.Eur J Epidemiol. 1997 Dec;13(8):951-7. doi: 10.1023/a:1007426304900. Eur J Epidemiol. 1997. PMID: 9476827
References
MeSH terms
Substances
LinkOut - more resources
Medical